A new start for 'Intestinal Research' as an official journal of AOCC

por Hibi, Toshifumi
Publicado 2016

Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome - Are Both Diseases Mutually Exclusive?

por Suzuki, Hidekazu, Hibi, Toshifumi
Publicado 2011

Editorial

por Hibi, Toshifumi, Rogler, Gerhard
Publicado 2022

Improving IBD outcomes in the era of many treatment options

por Kobayashi, Taku, Hibi, Toshifumi
Publicado 2023

Proton Pump Inhibitors and Gastritis

por Suzuki, Masayuki, Suzuki, Hidekazu, Hibi, Toshifumi
Publicado 2008

Gastric Epithelial Cell Modality and Proton Pump Inhibitor

por Masaoka, Tatsuhiro, Suzuki, Hidekazu, Hibi, Toshifumi
Publicado 2008

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication

por Nishizawa, Toshihiro, Suzuki, Hidekazu, Hibi, Toshifumi
Publicado 2009

Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis

por Suzuki, Hidekazu, Saito, Yoshimasa, Hibi, Toshifumi
Publicado 2009

Ghrelin and oxidative stress in gastrointestinal tract

por Suzuki, Hidekazu, Matsuzaki, Juntaro, Hibi, Toshifumi
Publicado 2011

What Is the Difference Between Helicobacter pylori-Associated Dyspepsia and Functional Dyspepsia?

por Suzuki, Hidekazu, Matsuzaki, Juntaro, Hibi, Toshifumi
Publicado 2011

Inflammatory Bowel Disease in Japan -Is It Similar to or Different from Westerns?-

por Okabayashi, Shinji, Kobayashi, Taku, Hibi, Toshifumi
Publicado 2020

Helicobacter pylori: present status and future prospects in Japan

por Suzuki, Hidekazu, Hibi, Toshifumi, Marshall, Barry James
Publicado 2007

Performing colonoscopy before steroid induction is associated with shorter steroid use in patients with ulcerative colitis

por Kobayashi, Taku, Udagawa, Eri, Hirose, Lisa, Hibi, Toshifumi
Publicado 2023

Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis

por Kobayashi, Taku, Uda, Akihito, Udagawa, Eri, Hibi, Toshifumi
Publicado 2020

Roles of oxidative stress in stomach disorders

por Suzuki, Hidekazu, Nishizawa, Toshihiro, Tsugawa, Hitoshi, Mogami, Sachiko, Hibi, Toshifumi
Publicado 2012

Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial

por Fukushima, Yasushi, Suzuki, Hidekazu, Matsuzaki, Juntaro, Kiyosue, Arihiro, Hibi, Toshifumi
Publicado 2012

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy

por Nishizawa, Toshihiro, Suzuki, Hidekazu, Suzuki, Masayuki, Takahashi, Masahiko, Hibi, Toshifumi
Publicado 2012

Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study

por Suzuki, Yasuo, Iida, Mitsuo, Ito, Hiroaki, Saida, Isamu, Hibi, Toshifumi
Publicado 2016

Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn’s Disease

por Suzuki, Yasuo, Iida, Mitsuo, Ito, Hiroaki, Tachikawa, Naoto, Hibi, Toshifumi
Publicado 2016

Impact of inflammatory bowel disease on Japanese patients’ quality of life: results of a patient questionnaire survey

por Ueno, Fumiaki, Nakayama, Yasuo, Hagiwara, Eiji, Kurimoto, Sarina, Hibi, Toshifumi
Publicado 2016